Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.94% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 32.38M.
Fairly Valued
The company’s latest PE is -7.32, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 49.70M shares, increasing 4.31% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 36.46K shares of this stock.